The Research and Development team at NiKang Therapeutics focuses on the discovery and development of innovative small molecule drugs for oncology. This team, comprising experts in drug product development, manufacturing, chemistry, and cancer biology, works collaboratively to identify and advance promising new therapies that target specific cancer mechanisms. Their goal is to deliver first-in-class and best-in-class small molecule treatments and immuno-oncology drugs that can potentially cure various types of cancer.
View all